April 12, 2022

Covestro Showcases Makrolon® RE Polycarbonate for Healthcare at Medical Development & Manufacturing West

Copied to clipboard

Covestro expands its groundbreaking low carbon footprint polycarbonate solutions to the medical industry

Covestro, a leading polymer company is proud to announce the expansion of its low carbon footprint product portfolio into the medical and healthcare space. Covestro began shipping its first low carbon footprint polycarbonate in late 2021, and now offers a drop-in, low carbon footprint medical-grade polycarbonate solution for use in healthcare products. Covestro’s Makrolon® RE polycarbonate grades are low carbon footprint thanks to the use of renewable electricity, as well as raw materials from mass-balanced bio-waste and residues.

Covestro has more than 50 years of experience manufacturing polycarbonate for the medical device industry. The company’s range of biocompatible, medical grade products are already used across a wide range of applications from IV access to surgical instruments to drug delivery solutions. Now those solutions will include options for companies who want to reduce their carbon footprint with an attributed portfolio of products.

Since receiving the ISCC Plus mass balance certification for two of its European sites at the end of 2020, Covestro has been supplying polycarbonates partly sourced from renewable feedstock and processing them using energy from renewable electricity plants. They are attributed using the mass balance approach and offer a drop-in product that does not disrupt existing processes or workflows.

“This is an important milestone toward our vision to be fully circular,” says Lily Wang, Head of Engineering Plastics at Covestro. “We’re taking steps to help our customers meet their sustainability targets and accelerate the transformation to a fully circular future.”

Covestro is gradually converting to alternative raw material sources including renewables as part of a comprehensive program to drive the transition to a circular economy. An integral piece of this is the mass balance approach, a chain of custody that allows fossil and alternative feedstock to be mixed in production but separated in bookkeeping. It is able to track materials through the value chain, allowing the attribution of alternative feedstock — such as bio-based raw materials — to selected end products. This allows raw material to be introduced into the value chain while taking advantage of the existing chemical infrastructure’s high efficiencies and economies of scale.

“Makrolon® RE polycarbonates provide the ideal set of low carbon footprint materials for customers within the healthcare space looking for a lower their carbon footprint without disrupting workflow,” George Paleos, Global Head, Healthcare, Engineering Plastics, Covestro LLC. “These materials offer the same quality and performance as fossil-based polycarbonates and can be seamlessly dropped-in to existing processes.”

To learn more about how your company can use Covestro’s Makrolon® RE polycarbonate to reduce the carbon footprint of your medical devices, please visit our Solution Center.

About Covestro LLC:

Covestro LLC is part of the global Covestro business, which is among the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from Covestro are also used in sectors such as sports and leisure, cosmetics and health, as well as in the chemical industry itself.

The company is committed to becoming fully circular and aims to become climate neutral by 2035 (scope 1 and 2). Covestro generated sales of around EUR 15.9 billion in fiscal 2021. At the end of 2021, the company had 50 production sites worldwide and employed approximately 17,900 people (calculated as full-time equivalents).

Find more information at www.covestro.us

Editor’s Note: Follow news from Covestro on Twitter: https://twitter.com/CovestroUS

Covestro Contact:

Russell Glorioso, Covestro LLC
Tel.: +1 412-525-9330

# # #

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Makrolon® is a registered trademarks of Covestro Group.